NPI registry status
Active
2026 NPPES data Pulmonary Disease Physician NPI 1093785487 D.O.
Verify on CMS → Carlos Obregon, D.O.
Pulmonary Disease Physician in Sewell, New Jersey.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 9,647 in Pulmonary Disease Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
4K
Medicare Part D claims · 732 beneficiaries · Pulmonary Disease Physician avg: 1K
Generic prescribing
53%
generic claims · 47% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
12.3/100
▼ 71 pts below national avg 83.5 · Penalty band
Industry payments
$2.4K
112 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Carlos Obregon, D.O. reported a CMS MIPS final score of 12.3/100 - below the 83.5 national average - and filed 3,795 Medicare Part D claims in 2024.
- 12.3/100
- MIPS score · -71 vs avg
- 4K
- Part D claims, 2024
- 53%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Carlos Obregon, D.O.
Federal records show an active NPI with both Medicare prescribing volume and a measured CMS quality score — objective registry data, not patient reviews.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1093785487), first enumerated 01/26/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 3,795 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
CMS quality reporting (MIPS)
Reported a CMS MIPS final score of 12.3/100 in the Quality Payment Program — a federal quality measure, not a patient review.
Source: CMS Quality Payment Program
- Reported
Board certification signal
Heuristic suggests board-certified status based on ABMS-eligible specialty taxonomy plus active CMS participation signals — not a direct ABMS verification.
- Reported
Industry payment transparency
$2.4K in reported industry payments (112 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1093785487 · Pulmonary Disease Physician
NPI-10 · ENUM-LEGACY · TAX-MID · MIPS-LOW · RX-MID · BOOK-THIN · PHOTO-FINISH
- NPI-10 1093785487
- ENUM-LEGACY 2006
- TAX-MID 10K Pulmonary Disease
- MIPS-LOW 12.3/100
- RX-MID 3,795
- BOOK-THIN 357 in New Jersey
- PHOTO-FINISH Mark Garfield · ±0.1
MIPS final-score neighbourhood
Same-specialty nationwide peers by CMS final score, not geographic proximity
- Enrique Diaz Guz…
Enrique Diaz Guzman Zavala
11.8 MIPS pts
- Sushil George · …
Sushil George
12.2 MIPS pts
- Obregon · this p…
Obregon · this provider
12.3 MIPS pts
- Mark Garfield · …
Mark Garfield
12.4 MIPS pts
- Mateen Ahmed · h…
Mateen Ahmed
12.7 MIPS pts
What this shows Nearest measured MIPS peers for this NUCC specialty (2023 performance year).
Carlos Obregon, D.O.'s MIPS score vs every measured U.S. clinician
CMS Merit-based Incentive Payment System (MIPS) final score, 2023, the federal quality measure. Clinicians whose score CMS assigned without scoring any category are excluded.
12 ≥ 2nd percentile 2% of 454,083 measured providers are in lower value bands
Each bar is a band; taller bars hold more measured providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative whole-score-point band: it counts only measured clinicians in lower score bands. A CMS MIPS metric is not a recommendation or a clinical-quality rating by PlainDoctor. See methodology § corpus placement.
Source CMS Merit-based Incentive Payment System (MIPS) · 2023
Where Carlos Obregon, D.O. sits
This provider among pulmonary disease physician peers
Across the 2,467 pulmonary disease physician providers who report both Medicare Part D prescribing and a MIPS quality score, Carlos Obregon, D.O. writes more Part D claims than 90% of them and scores higher on MIPS quality than 1% - placing this provider in the high-volume, lower-quality quadrant. Volume reflects patient-panel size and specialty, not quality; the two axes are independent.
Each dot is one pulmonary disease physician peer from a representative sample of 60; the gold marker is Carlos Obregon, D.O.. Source: CMS Medicare Part D Prescriber data and the CMS Merit-based Incentive Payment System, 2023.
✓
Board certification likely (heuristic, not verified)
Carlos Obregon, D.O. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting - signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Carlos Obregon, D.O.?
Below national averagePrimary specialty
Pulmonary Disease Physician
Medicare Part D claims
3,795 153% vs specialty avg
MIPS final score
12.3/100 71.2 pts vs avg
Specialty distribution in New Jersey
How Pulmonary Disease Physician compares to other specialties among New Jersey providers
Medicare quality performance, MIPS
Carlos Obregon, D.O.'s 2023 MIPS final score plotted against the Pulmonary Disease Physician national average
- MIPS Final Score
- 12.3/100
- vs 83.5 national avg · 2023 performance year
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1093785487 |
|---|---|
| Specialty | Pulmonary Disease Physician |
| Credentials | D.O. |
| Gender | Male |
| NPI Issued | 01/26/2006 |
CMS Quality Score (MIPS)
Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.
12.3123
Final Score
Measured-score avg: 83.5
0
Quality
41.041
Cost
Reporting: Individual
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Carlos Obregon, D.O.. Source: openpaymentsdata.cms.gov.
Total received
$2.4K
Largest payer
INTUITIVE SURGICAL, INC.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
Carlos Obregon, D.O. - brand share 47.0%
Pulmonary Disease Physician average
47% brand-name claims vs 53% generic, on 3,795 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
3,795
Total Claims
$3.6M
Total Drug Cost
732
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 6,636.333
- Total Day Supply
- 188,723
- Brand vs Generic
- 47% brand / 53% generic
- Brand Drug Cost
- $3.4M
- Generic Drug Cost
- $182K
- Antibiotic Claims
- 145
Patient Demographics
- Average Patient Age
- 75.0 years
- Avg HCC Risk Score
- 1.70
- Gender Split
- 63% female / 37% male
- Age Distribution
- <65: 44, 65-74: 295, 75-84: 312, 85+: 81
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Carlos Obregon, D.O. prescribes most
Top Medicare Part D drugs by claim count, 2024
- Albuterol Sulfate …
Albuterol Sulfate Hfa
454 claims
- Arnuity Ellipta
Arnuity Ellipta
316 claims
- Montelukast Sodium
Montelukast Sodium
311 claims
- Furosemide
Furosemide
300 claims
- Prednisone
Prednisone
211 claims
- Breo Ellipta
Breo Ellipta
196 claims
- Fluticasone Propio…
Fluticasone Propionate
191 claims
- Fluticasone-Salmet… 158
Fluticasone-Salmeterol
158 claims
| Drug | Claims |
|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 454 |
| Arnuity Ellipta Fluticasone Furoate | 316 |
| Montelukast Sodium | 311 |
| Furosemide | 300 |
| Prednisone | 211 |
| Breo Ellipta Fluticasone/Vilanterol | 196 |
| Fluticasone Propionate | 191 |
| Fluticasone-Salmeterol Fluticasone Propion/Salmeterol | 158 |
| Eliquis Apixaban | 84 |
| Opsumit Macitentan | 77 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Pulmonary Disease Physician Overview
How Carlos Obregon, D.O. fits within the Pulmonary Disease Physician landscape nationally.
9,647
Pulmonary Disease Physician Providers in US
53
States with Pulmonary Disease Physician
1,498
Avg Claims per Provider
Carlos Obregon, D.O.'s 3,795 claims are above the specialty average of 1,498.
Nationwide Pulmonary Disease Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Obregon, both outside New Jersey so the neighborhoods are not geographic containment.
Similar MIPS final score
Nearest same-specialty clinicians by CMS MIPS final score (12.3 here).
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Pulmonary Disease Physician Providers in New Jersey
Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as Obregon.
One of 357 Pulmonary Disease Physician providers enrolled in New Jersey, 5 are shown here.
Dr. Abdelrhman Abo-Zed
MD
Branchburg, NJ
Dr. Vincent Acampora
DO
Cherry Hill, NJ
Dr. Pankaja Achar
MD
Newark, NJ
Dr. William Adams
D.O.
Atlantic City, NJ
Dr. Abhishek Agarwal
MD
Marlton, NJ
Compare Pulmonary Disease Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Carlos Obregon, D.O.'s specialty? ▼
Carlos Obregon, D.O. specializes in Pulmonary Disease Physician and practices in Sewell, New Jersey. Credentials: D.O..
How much does Carlos Obregon, D.O. prescribe under Medicare Part D? ▼
In 2024, Carlos Obregon, D.O. wrote 3,795 Medicare Part D claims totaling $3.6M in drug costs for 732 beneficiaries.
What is Carlos Obregon, D.O.'s Medicare quality score? ▼
Carlos Obregon, D.O. has a CMS MIPS Final Score of 12.3/100 (Quality: 0, Cost: 41). The average MIPS Final Score across the 454,083 clinicians with at least one published category score is 83.5; clinicians whose score CMS assigned without scoring any category are excluded from that average. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is Carlos Obregon, D.O. located? ▼
Carlos Obregon, D.O. is located at 100A KINGS WAY WEST, Sewell, NJ, 08080. Phone: (856) 218-8080.
What is Carlos Obregon, D.O.'s NPI number? ▼
Carlos Obregon, D.O.'s National Provider Identifier (NPI) is 1093785487, issued on 01/26/2006.
Does Carlos Obregon, D.O. prescribe more brand-name or generic drugs? ▼
Carlos Obregon, D.O.'s prescribing is 47% brand-name and 53% generic drugs by claim count, with $3.4M in brand drug costs.
How many Pulmonary Disease Physician providers are there in the US? ▼
There are 9,647 Pulmonary Disease Physician providers across 53 states in the US. The average Pulmonary Disease Physician provider writes 1,498 Medicare Part D claims per year.
What drugs does Carlos Obregon, D.O. prescribe most often? ▼
Based on 2024 Medicare Part D data, Carlos Obregon, D.O.'s most frequently prescribed drugs include Albuterol Sulfate Hfa, Arnuity Ellipta, Montelukast Sodium. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Carlos Obregon, D.O. accept Medicare? ▼
Carlos Obregon, D.O. appears in CMS Medicare data with 3,795 Part D claims and 732 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Carlos Obregon, D.O.'s credentials? ▼
Carlos Obregon, D.O.'s NPI is 1093785487 with credentials D.O.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Quality Performance
- CMS Merit-based Incentive Payment System (MIPS) - 2023 performance year.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.